Follow
Megala Ramasamy
Megala Ramasamy
Graduate Student, University of Waterloo
Verified email at uwaterloo.ca
Title
Cited by
Cited by
Year
Evaluating the inherent osteogenic and angiogenic potential of mesoporous silica nanoparticles to augment vascularized bone tissue formation
H Kanniyappan, M Venkatesan, J Panji, M Ramasamy, V Muthuvijayan
Microporous and Mesoporous Materials 311, 110687, 2021
182021
Inexpensive and rapid fabrication of PDMS microfluidic devices for biological testing applications using low cost commercially available 3D printers
M Ramasamy, B Ho, CM Phan, N Qin, CL Ren, L Jones
Journal of Micromechanics and Microengineering 33 (10), 105016, 2023
62023
Corrigendum to “Evaluating the inherent osteogenic and angiogenic potential of mesoporous silica nanoparticles to augment vascularized bone tissue formation”[Microporous …
H Kanniyappan, M Venkatesan, J Panji, M Ramasamy, V Muthuvijayan
Microporous and Mesoporous Materials 319, 111083, 2021
42021
pH-responsive drug release from positively charged mesoporous silica nanoparticles and their potential for anticancer drug delivery
H Kanniyappan, J Jose, S Chakraborty, M Ramasamy, V Muthuvijayan
Journal of the Australian Ceramic Society 59 (1), 207-220, 2023
12023
Fabrication of microfluidic chip using 3D printing for ocular cell studies
M Ramasamy
University of Waterloo, 2023
2023
Fabrication of a microfluidic chip using 3D printing for evaluating ocular cytotoxicity
CM Phan, M Ramasamy, B Ho, A Hui, LW Jones
Investigative Ophthalmology & Visual Science 64 (8), 3586-3586, 2023
2023
Fabrication of a microfluidic chip for ophthalmic drug delivery studies using 3D printing
M Ramasamy, B Ho, CM Phan, LW Jones
Investigative Ophthalmology & Visual Science 64 (8), 1336-1336, 2023
2023
PDMS microfluidic devices fabricated from commercial 3D printers support growth of viable HCECs and enable cell biological assays for low-cost high-throughput screening
B Ho, CM Phan, M Ramasamy, A Hui, LW Jones
Investigative Ophthalmology & Visual Science 64 (8), 5400-5400, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–8